Scientists at the ALS Therapy Development Institute are conducting research on this small molecule to determine if it can be an effective treatment for ALS by addressing the hyperexcitability of motor neurons of PALS.
Our team is working to finalize the formulation strategy that will be used throughout the preclinical testing of this compound.
Topics in the Pipeline